Literature DB >> 2474733

Immunosuppressive properties of FK-506 and rapamycin.

A W Thomson, J Woo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2474733     DOI： 10.1016/s0140-6736(89)90616-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A.

Authors:  Jonathan G Bilmen; Laura L Wootton; Francesco Michelangeli
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

2.  Approach to withdrawal from tacrolimus in a fully allogeneic murine skin graft model.

Authors:  H Uchiyama; Y Kong; K Kishihara; K Sugimachi; K Nomoto
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

3.  Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.

Authors:  Y Koltin; L Faucette; D J Bergsma; M A Levy; R Cafferkey; P L Koser; R K Johnson; G P Livi
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

Review 4.  Emerging therapeutic targets in endometrial cancer.

Authors:  Konstantin J Dedes; Daniel Wetterskog; Alan Ashworth; Stan B Kaye; Jorge S Reis-Filho
Journal:  Nat Rev Clin Oncol       Date:  2011-01-11       Impact factor: 66.675

5.  Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface.

Authors:  Uddhav K Shigdel; Seung-Joo Lee; Mathew E Sowa; Brian R Bowman; Keith Robison; Minyun Zhou; Khian Hong Pua; Dylan T Stiles; Joshua A V Blodgett; Daniel W Udwary; Andrew T Rajczewski; Alan S Mann; Siavash Mostafavi; Tara Hardy; Sukrat Arya; Zhigang Weng; Michelle Stewart; Kyle Kenyon; Jay P Morgenstern; Ende Pan; Daniel C Gray; Roy M Pollock; Andrew M Fry; Richard D Klausner; Sharon A Townson; Gregory L Verdine
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-30       Impact factor: 11.205

Review 6.  The Role of mTOR Signaling as a Therapeutic Target in Cancer.

Authors:  Nadezhda V Popova; Manfred Jücker
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.